BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018
| Autor: | Dan Clutterbuck, Ingrid Young, Justin Harbottle, Valentina Cambiano, Sheena McCormack, David Asboe, Mags Portman, Michael Brady, Nigel Field, Melinda Tenant-Flowers, Monica Desai, Ed Wilkins, Killian Quinn, Alison Rodger, Adrian Palfreeman, Zahra Jamal |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty business.industry Health Policy Human immunodeficiency virus (HIV) MEDLINE HIV Infections medicine.disease_cause 030112 virology Clinical Practice 03 medical and health sciences Pre-exposure prophylaxis 0302 clinical medicine Infectious Diseases Dosing schedules Family medicine medicine Humans Pharmacology (medical) Pre-Exposure Prophylaxis 030212 general & internal medicine Hiv acquisition Risk assessment business |
| Zdroj: | HIV medicine. 20 |
| ISSN: | 1468-1293 |
| Popis: | We aim to provide evidence-based guidance on best clinical practice in the provision, monitoring and support of pre-exposure prophylaxis (PrEP) for the prevention of HIV acquisition. The guidelines include: (i) Guidance on risk assessment prior to PrEP; (ii) Baseline assessment; (iii) Dosing schedules; (iv) Monitoring; (v) Supporting adherence; (vi) Buying generic PrEP; and (vii) Cost-effectiveness. The guidelines are aimed at clinical professionals directly involved in, and responsible for, HIV prevention, and at community advocates and organisations responsible for supporting HIV prevention strategies in those at risk of HIV acquisition. A detailed review of the evidence base is included in Section 4. Sections 5 to 7 are intended to offer practical guidance in risk assessment, starting PrEP, ongoing management while on PrEP and stopping PrEP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text